RxDoctor Payments Data

Andrew Illig, DO

Pain Medicine · Stamford, CTNPI 1952566580

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,711 of the $2,421 with a category attached, or 70.6%. 7 manufacturers reported payments, led by Boston Scientific at 46.1% of the total. Reporting peaked in 2019 at $1,327 and has fallen 89.3% since, to $142 in 2025.

$2,421in general payments, 2019–2025

Across 35 payments — averaging $69.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Nevro Corp.$698
  • Medtronic$175
  • Si-bone, Inc.$151
  • Smith+Nephew$142
  • Curonix LLC$121
  • plus $18 from 1 others

What the payments were for

  • Travel & lodging$71129%
  • Food & beverage$1,71171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,421 in reported general payments places this provider in the 55th percentile of 69 pain medicine providers in Connecticut.

See all pain medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$190,869
Medicare patients
288
Services billed
2,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SavellaMilnacipran Hcl11$4,587
Gabapentin231$3,207
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$1,064
Pregabalin48$1,036
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$681
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$677
Oxycodone Hcl36$650
Diclofenac Sodium12$398
Tramadol Hcl89$388
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen53$224
Nabumetone17$223
Acetaminophen-CodeineAcetaminophen With Codeine18$213
Meloxicam54$202
Ibuprofen15$195
Cyclobenzaprine Hcl33$190

Paid to pharmacies, not to this prescriber.

Other pain medicine in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →